Pyrazinamide 00054-0812-29
- Manufacturer
- Hikma Pharmaceuticals Usa Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 30, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA081319
Need to source Pyrazinamide? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pyrazinamide | 500 mg/1 |
Drug Class
Antimycobacterial [EPC]Antimycobacterial [EPC]
Selected Package
00054-0812-29Selected500 TABLET in 1 CONTAINER (0054-0812-29)
Other packages for this product(3)
60 TABLET in 1 CONTAINER (0054-0812-21)
90 TABLET in 1 CONTAINER (0054-0812-22)
100 TABLET in 1 CONTAINER (0054-0812-25)